Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
ACHN

Achillion

$3.43

-0.02 (-0.58%)

, JNJ

Johnson & Johnson

$137.11

-1.23 (-0.89%)

12:10
11/22/17
11/22
12:10
11/22/17
12:10
Hot Stocks
Johnson & Johnson reports sale of 18.37M shares of Achillion »

In a regulatory filing,…

ACHN

Achillion

$3.43

-0.02 (-0.58%)

JNJ

Johnson & Johnson

$137.11

-1.23 (-0.89%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

Yesterday
JNJ

Johnson & Johnson

$138.81

0.88 (0.64%)

11:44
11/21/17
11/21
11:44
11/21/17
11:44
Hot Stocks
Janssen announces submission of sBLA to expand indication for Darzalex »

Janssen Biotech, one of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

GNMSF

Genmab

$186.00

-7.4706 (-3.86%)

, JNJ

Johnson & Johnson

$137.93

-0.07 (-0.05%)

07:04
11/21/17
11/21
07:04
11/21/17
07:04
Hot Stocks
Genmab announces European regulatory submission for daratumumab »

Genmab (GNMSF) announced…

GNMSF

Genmab

$186.00

-7.4706 (-3.86%)

JNJ

Johnson & Johnson

$137.93

-0.07 (-0.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

Monday
JNJ

Johnson & Johnson

$138.00

-0.87 (-0.63%)

08:43
11/20/17
11/20
08:43
11/20/17
08:43
Hot Stocks
EU extends license for Janssen's Zytiga plus prednisone »

Janssen-Cilag…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

GERN

Geron

, JNJ

Johnson & Johnson

$138.00

-0.87 (-0.63%)

07:40
11/20/17
11/20
07:40
11/20/17
07:40
Hot Stocks
Geron doses first patient in expanded Part 1 of IMerge Phase 2/3 clinical trial »

Geron (GERN) announced…

GERN

Geron

JNJ

Johnson & Johnson

$138.00

-0.87 (-0.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

  • 09

    Dec

  • 14

    Dec

Thursday
JNJ

Johnson & Johnson

$138.76

-0.34 (-0.24%)

14:25
11/16/17
11/16
14:25
11/16/17
14:25
Hot Stocks
Texas jury returns $247M verdict against J&J in defective hip implants case »

A federal court jury in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

JNJ

Johnson & Johnson

$138.72

-0.38 (-0.27%)

13:43
11/16/17
11/16
13:43
11/16/17
13:43
Periodicals
Johnson & Johnson not liable for woman's asbestos illness, Law360 reports »

A California Jury ruled…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

JNJ

Johnson & Johnson

$138.82

-0.28 (-0.20%)

13:33
11/16/17
11/16
13:33
11/16/17
13:33
Periodicals
Breaking Periodicals news story on Johnson & Johnson »

J&J beats LA suit…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

RHHBY

Roche

$28.73

-0.12 (-0.42%)

, ABBV

AbbVie

$93.76

-0.99 (-1.04%)

05:33
11/16/17
11/16
05:33
11/16/17
05:33
Recommendations
Roche, AbbVie, Novartis, Bayer, Johnson & Johnson, Zoetis, Eli Lilly, Merck, Novo Nordisk, AstraZeneca analyst commentary at Jefferies »

Jefferies names Roche new…

RHHBY

Roche

$28.73

-0.12 (-0.42%)

ABBV

AbbVie

$93.76

-0.99 (-1.04%)

NVS

Novartis

$82.60

-0.43 (-0.52%)

BAYRY

Bayer

$31.97

-0.04 (-0.12%)

JNJ

Johnson & Johnson

$139.10

-0.39 (-0.28%)

ZTS

Zoetis

$69.62

-0.28 (-0.40%)

LLY

Eli Lilly

$82.19

-0.3 (-0.36%)

MRK

Merck

$54.80

-0.19 (-0.35%)

NVO

Novo Nordisk

$49.67

-0.17 (-0.34%)

AZN

AstraZeneca

$33.39

0.14 (0.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Nov

  • 16

    Nov

  • 16

    Nov

  • 28

    Nov

  • 30

    Nov

  • 30

    Nov

  • 30

    Nov

  • 04

    Dec

  • 06

    Dec

  • 09

    Dec

  • 14

    Dec

  • 23

    Dec

  • 02

    Feb

  • 23

    Feb

  • 17

    May

Over a week ago
JNJ

Johnson & Johnson

$139.76

0.2 (0.14%)

, SSNLF

Samsung

06:20
11/14/17
11/14
06:20
11/14/17
06:20
Periodicals
J&J's Janssen drops suit against Samsung Bioepis' RA drug, Reuters reports »

Janssen Biotech, a unit…

JNJ

Johnson & Johnson

$139.76

0.2 (0.14%)

SSNLF

Samsung

BIIB

Biogen

$315.71

5.27 (1.70%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.